Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06516172
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-05-28
Brief Title:
The Bern Rehab Registry
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The Bern Rehab Registry - a Prospective Cohort Study in Patients With Chronic Non-communicable Diseases Participating in a Comprehensive Rehabilitation Programme
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
BernRehabReg
Brief Summary:
This study examines the health outcomes of patients with long-term illnesses such as cancer heart lung or musculoskeletal diseases who participate in a rehabilitation programme The programme may involve staying in a facility inpatient visiting a facility outpatient home-based care supported by digital health tools telerehabilitation or a combination of facility- and home-based options
The key health outcomes being measured include physical fitness and strength body composition like body fat and muscle mass specific risk factors related to the diseases and patients self-reported health and experience outcomes such as feelings of anxiety depression fatigue overall quality of life and satisfaction with the rehabilitation programme
These measurements provide important information about the patients lung heart and muscle health as well as their mental well-being They also help to predict the likelihood of further health complications the chance of needing to be hospitalized again and overall quality of life This information is useful for improving the quality of care tailoring future provision of rehabilitation services and long-term care for patients with chronic conditions
Additionally the study will provide insights into how new technologies like telerehabilitation are implemented including how well they are adopted followed and accepted by patients
The key health outcomes being measured include physical fitness and strength body composition like body fat and muscle mass specific risk factors related to the diseases and patients self-reported health and experience outcomes such as feelings of anxiety depression fatigue overall quality of life and satisfaction with the rehabilitation programme
These measurements provide important information about the patients lung heart and muscle health as well as their mental well-being They also help to predict the likelihood of further health complications the chance of needing to be hospitalized again and overall quality of life This information is useful for improving the quality of care tailoring future provision of rehabilitation services and long-term care for patients with chronic conditions
Additionally the study will provide insights into how new technologies like telerehabilitation are implemented including how well they are adopted followed and accepted by patients
Detailed Description:
Background
The global demographic landscape is shifting towards an aging population coupled with a rise in chronic non-communicable diseases that contribute to disability and escalating healthcare costs Recognizing this the World Health Organization WHO has identified rehabilitation as a key strategy for health in the 21st century
Aim
The aim of this prospective cohort study is to assess the outcomes of disease-specific comprehensive rehabilitation programmes at a tertiary referral center to improve the quality of care and formulate novel research questions
Methods
Consecutive patients with cancer cardiovascular musculoskeletal or pulmonary diseases referred for comprehensive rehabilitation to the Centre for Rehabilitation Sports Medicine two locations - Berner Reha Centre and Inselspital of the Insel Group Bern Switzerland will be included Patients will be counselled by trained advanced practice nurses and type of delivery of the rehabilitation programme will be based on medical needs and patient preferences Three-week inpatient programmes are performed at the Berner Reha Centre and Inselspital Twelve-week outpatient programmes are performed at the Inselspital and delivered as centre-based digitally-enhanced centre- and home-based or home-based digitaltele rehabilitation
Outcome assessments will be based on the framework of the International Classification of Functioning Disability and Health ICF of the World Health Organisation
The global demographic landscape is shifting towards an aging population coupled with a rise in chronic non-communicable diseases that contribute to disability and escalating healthcare costs Recognizing this the World Health Organization WHO has identified rehabilitation as a key strategy for health in the 21st century
Aim
The aim of this prospective cohort study is to assess the outcomes of disease-specific comprehensive rehabilitation programmes at a tertiary referral center to improve the quality of care and formulate novel research questions
Methods
Consecutive patients with cancer cardiovascular musculoskeletal or pulmonary diseases referred for comprehensive rehabilitation to the Centre for Rehabilitation Sports Medicine two locations - Berner Reha Centre and Inselspital of the Insel Group Bern Switzerland will be included Patients will be counselled by trained advanced practice nurses and type of delivery of the rehabilitation programme will be based on medical needs and patient preferences Three-week inpatient programmes are performed at the Berner Reha Centre and Inselspital Twelve-week outpatient programmes are performed at the Inselspital and delivered as centre-based digitally-enhanced centre- and home-based or home-based digitaltele rehabilitation
Outcome assessments will be based on the framework of the International Classification of Functioning Disability and Health ICF of the World Health Organisation
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None